ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Immunome Inc

Immunome Inc (IMNM)

10.66
-0.10
(-0.93%)
終値: 1月9日 6:00AM
10.66
0.00
( 0.00% )
取引時間後: 6:20AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
10.66
買値
10.27
売値
11.09
出来高
334,631
10.35 日の範囲 10.85
8.97 52 週間の範囲 30.958
時価総額
前日終値
10.76
始値
10.72
最終取引時間
06:01:44
財務取引量
US$ 3,521,481
VWAP
10.5235
平均取引量 (3 か月)
810,027
発行済株式数
62,416,845
配当利回り
-
PER
-6.23
1 株当たり利益 (EPS)
-1.71
歳入
14.02M
純利益
-106.81M

Immunome Inc について

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious... Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Immunome Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker IMNM. The last closing price for Immunome was US$10.76. Over the last year, Immunome shares have traded in a share price range of US$ 8.97 to US$ 30.958.

Immunome currently has 62,416,845 shares in issue. The market capitalisation of Immunome is US$671.61 million. Immunome has a price to earnings ratio (PE ratio) of -6.23.

IMNM 最新ニュース

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

SAN FRANCISCO and SINGAPORE, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat...

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on January 2, 2025...

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on December 2, 2024...

Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome’s management will...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.04-0.37383177570110.711.610.4755611410.97419414CS
4-3.33-23.802716225913.9914.110.1184656511.26448819CS
12-1.62-13.192182410412.2815.1258.9781002711.52393452CS
26-1.46-12.046204620512.1216.818.9772034112.8220523CS
52-0.69-6.0792951541911.3530.9588.9776266615.44465275CS
156-1.02-8.7328767123311.6830.9582.0931503613.79577311CS
260-5-31.928480204315.6663.782.0928183415.72146231CS

IMNM - Frequently Asked Questions (FAQ)

What is the current Immunome share price?
The current share price of Immunome is US$ 10.66
How many Immunome shares are in issue?
Immunome has 62,416,845 shares in issue
What is the market cap of Immunome?
The market capitalisation of Immunome is USD 671.61M
What is the 1 year trading range for Immunome share price?
Immunome has traded in the range of US$ 8.97 to US$ 30.958 during the past year
What is the PE ratio of Immunome?
The price to earnings ratio of Immunome is -6.23
What is the cash to sales ratio of Immunome?
The cash to sales ratio of Immunome is 47.46
What is the reporting currency for Immunome?
Immunome reports financial results in USD
What is the latest annual turnover for Immunome?
The latest annual turnover of Immunome is USD 14.02M
What is the latest annual profit for Immunome?
The latest annual profit of Immunome is USD -106.81M
What is the registered address of Immunome?
The registered address for Immunome is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Immunome website address?
The website address for Immunome is www.immunome.com
Which industry sector does Immunome operate in?
Immunome operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
CHNRChina Natural Resources Inc
US$ 1.07
(43.22%)
3.74M
MBIOMustang Bio Inc
US$ 0.3202
(37.48%)
8.26M
KAVLKaival Brands Innovations Group Inc
US$ 1.3202
(34.71%)
2.32M
DRCTDirect Digital Holdings Inc
US$ 1.44
(21.01%)
7.85k
DBVTDBV Technologies SA
US$ 4.51
(18.06%)
809.34k
XXII22nd Century Group Inc
US$ 6.05
(-24.94%)
347.46k
SILOSilo Pharma Inc
US$ 1.40
(-18.13%)
507.43k
IMGCIMG Inc
US$ 0.6906
(-14.73%)
169.16k
LSHLakeside Holding Ltd
US$ 2.91
(-12.61%)
66.23k
MMVMultiMetaVerse Holdings Ltd
US$ 0.448
(-10.40%)
20.73k
MBIOMustang Bio Inc
US$ 0.3202
(37.48%)
8.26M
CHNRChina Natural Resources Inc
US$ 1.07
(43.22%)
3.74M
ESGEiShares Inc iShares ESG Aware MSCI EM ETF
US$ 33.4874
(0.08%)
3.06M
XTIAXTI Aerospace Inc
US$ 0.05
(0.00%)
2.72M
KAVLKaival Brands Innovations Group Inc
US$ 1.3202
(34.71%)
2.32M

IMNM Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock